Trademark: 79292986
Word
OPERATING SYSTEM OF LIFE
Status
Registered
Status Code
700
Status Date
Tuesday, February 21, 2023
Serial Number
79292986
Registration Number
6982346
Registration Date
Tuesday, February 21, 2023
Mark Type
4000
Filing Date
Monday, May 11, 2020
Published for Opposition
Tuesday, May 18, 2021

Trademark Owner History
Bit Bio Limited - Original Registrant

Classifications
40 Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and/or veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not live; all of the foregoing excluding vaccines and RNA-based therapeutics
9 Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use; all of the foregoing excluding vaccines and RNA-based therapeutics
29 Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live
5 Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for medical use in drug screening; Cell preparations for genetic testing and screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; Tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplements
1 Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research; all of the foregoing excluding vaccines and RNA-based therapeutics
42 Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services for scientific, research, clinical, therapeutic and manufacturing purposes; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; all of the foregoing excluding vaccines and RNA-based therapeutics

Trademark Events
Jun 11, 2023
Final Decision Transaction Processed By Ib
May 22, 2023
Final Disposition Notice Sent To Ib
May 22, 2023
Final Disposition Processed
May 21, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 21, 2023
Notice Of Registration Confirmation Emailed
Feb 21, 2023
Registered-Principal Register
Jan 12, 2023
Ttab Release Case To Trademarks
Jan 12, 2023
Opposition Terminated No. 999999
Jan 12, 2023
Opposition Dismissed No. 999999
Sep 11, 2022
Notification Of Possible Opposition - Processed By Ib
Aug 24, 2022
Notification Of Possible Opposition Sent To Ib
Aug 24, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 25, 2021
Refusal Processed By Ib
Sep 16, 2021
Opposition Instituted No. 999999
Sep 13, 2021
Opposition Notice (Ib Refusal) Sent To Ib
Sep 13, 2021
Opposition Notice (Ib Refusal) Created
Jun 9, 2021
Extension Of Time To Oppose Received
May 18, 2021
Official Gazette Publication Confirmation E-Mailed
May 18, 2021
Published For Opposition
May 17, 2021
Notification Processed By Ib
Apr 28, 2021
Notification Of Possible Opposition Sent To Ib
Apr 28, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 28, 2021
Notification Of Notice Of Publication E-Mailed
Apr 12, 2021
Withdrawn From Issue - Managing Attorney Request
Apr 9, 2021
Attorney Review Completed
Apr 9, 2021
Correction From Ib Entered - Attorney Review Required
Mar 23, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 23, 2021
Published For Opposition
Mar 22, 2021
Notification Processed By Ib
Mar 20, 2021
Correction Transaction Received From Ib
Mar 3, 2021
Notification Of Possible Opposition Sent To Ib
Mar 3, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 3, 2021
Notification Of Notice Of Publication E-Mailed
Feb 15, 2021
Approved For Pub - Principal Register
Feb 12, 2021
Teas/Email Correspondence Entered
Feb 11, 2021
Correspondence Received In Law Office
Feb 11, 2021
Teas Response To Office Action Received
Jan 5, 2021
Letter Of Protest Evidence Reviewed-No Further Action Taken
Dec 7, 2020
Letter Of Protest Evidence Forwarded
Oct 19, 2020
Refusal Processed By Ib
Sep 30, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 30, 2020
Refusal Processed By Mpu
Sep 9, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Sep 8, 2020
Non-Final Action Written
Sep 8, 2020
Application Filing Receipt Mailed
Sep 4, 2020
Assigned To Examiner
Sep 4, 2020
New Application Office Supplied Data Entered
Sep 3, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24